Voyager Therapeutics Inc. (VYGR)
NASDAQ · Healthcare
Voyager Therapeutics Inc. Shareholder Equity 2015–2025
Voyager Therapeutics Inc. annual shareholder equity history from 2015 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Voyager Therapeutics Inc. shareholder equity as of December 31, 2025: 196.1M, a 34.59% decrease year-over-year.
- Voyager Therapeutics Inc. shareholder equity for 2025 were 196.1M, a 34.59% decrease from 2024.
- Voyager Therapeutics Inc. shareholder equity for 2024 were 299.8M, a 26.84% increase from 2023.
- Voyager Therapeutics Inc. shareholder equity for 2023 were 236.3M, a 300.41% increase from 2022.
- Voyager Therapeutics Inc. shareholder equity for 2022 were 59.0M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Voyager Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $196 |
| 2024 | $300 |
| 2023 | $236 |
| 2022 | $59 |
| 2021 | $95 |
| 2020 | $154 |
| 2019 | $100 |
| 2018 | $46 |
| 2017 | $134 |
| 2016 | $136 |
| 2015 | $169 |
Voyager Therapeutics Inc. Shareholder Equity — FAQ
Voyager Therapeutics Inc. (VYGR) shareholder equity over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VYGR's shareholder equity history?
The chart and table above show Voyager Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.